Schematic overview of the model.

This model focuses on the effects of a personalized discharge letter on first-time BCC patients. Once patients receive a new diagnosis, they no longer meet the criteria of the first group. Expert consensus was reached over the fact that any new diagnosis might influence the effect of the letter, both positively and negatively. To solely model the effect of the letter, patients within the model cannot return to the first state once they have left it.

Verfasser: Sven van Egmond (10492184)
Ella D. van Vliet (11993567)
Marlies Wakkee (7046249)
Loes M. Hollestein (7046234)
Xavier G. L. V. Pouwels (8694270)
Hendrik Koffijberg (388563)
Yesim Misirli (11993570)
Rachel S. L. A. Bakkum (11993573)
Maarten T. Bastiaens (11993576)
Nicole A. Kukutsch (7046243)
Albert J. Oosting (11993579)
Elsemieke I. Plasmeijer (11993582)
Annik van Rengen (11993585)
Kees-Peter de Roos (10492193)
Tamar E. C. Nijsten (4620826)
Esther de Vries (3932951)
Esther W. de Bekker-Grob (7399718)
Dokumenttyp: Image
Erscheinungsdatum: 2022
Schlagwörter: Medicine / Cell Biology / Developmental Biology / Marine Biology / Cancer / Infectious Diseases / Virology / personalized discharge letter / one visit post / 45 per patient / basal cell carcinomas / time bcc patients / dutch bcc guideline / national budget impact / budget impact analyses / keratinocyte carcinomas consist / substantial cost savings / risk bcc patients / center intervention study / care </ p / budget impact / keratinocyte carcinomas / risk tumors / xlink \ / > / usual care / recommended according / rapidly growing / outcome measures / five years / based cost / approximately 80 / 7 million / -&# 8364
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-29019366
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.1371/journal.pone.0260978.g001